Related Experiment Videos

Course, management and outcome of oral-anticoagulant-related intracranial haemorrhages

J Berwaerts1, O J Robb, R S Dykhuizen

  • 1Clinical Pharmacology Unit, Aberdeen Royal Infirmary, Foresterhill. Joris-M-Berwaerts@sbphrd

Scottish Medical Journal
|November 4, 2000
PubMed

Insights

Oral anticoagulant-related intracranial hemorrhages show higher in-hospital mortality than unrelated ones. Reversal measures were not consistently applied, highlighting a need for further research into anticoagulant reversal strategies.

Area of Science:

  • Neurology
  • Hematology
  • Radiology

Background:

  • Oral anticoagulants (OACs) are widely used but increase bleeding risk.
  • Intracranial hemorrhage (ICH) is a serious complication of OAC therapy.
  • Understanding OAC-related ICH characteristics is crucial for patient management.

Purpose of the Study:

  • To compare clinical and radiological features of OAC-related ICH versus non-OAC ICH.
  • To evaluate OAC reversal strategies and their short-term outcomes.
  • To identify factors influencing mortality in OAC-related ICH.

Main Methods:

  • Retrospective analysis of 68 patients with ICH over six years.
  • Comparison of clinical data and CT scan findings between OAC users and non-users.
  • Assessment of OAC reversal measures and in-hospital mortality.

Main Results:

  • No significant differences in clinical features or hematoma size (subdural or intracerebral) between OAC-related and unrelated ICH.
  • OAC reversal measures were not administered in 38% of OAC-treated patients.
  • In-hospital mortality was significantly higher for OAC-related ICH (38%) compared to unrelated ICH (18%).

Conclusions:

  • OAC-related ICH presents similarly to non-OAC ICH on initial assessment but carries a worse prognosis.
  • Inconsistent application of OAC reversal therapies may contribute to poorer outcomes.
  • Prospective studies are needed to optimize anticoagulant reversal and improve outcomes in OAC-related ICH.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...